Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Mol Brain ; 14(1): 139, 2021 09 10.
Article En | MEDLINE | ID: mdl-34507588

Chronic pain easily leads to concomitant mood disorders, and the excitability of anterior cingulate cortex (ACC) pyramidal neurons (PNs) is involved in chronic pain-related anxiety. However, the mechanism by which PNs regulate pain-related anxiety is still unknown. The GABAergic system plays an important role in modulating neuronal activity. In this paper, we aimed to study how the GABAergic system participates in regulating the excitability of ACC PNs, consequently affecting chronic inflammatory pain-related anxiety. A rat model of CFA-induced chronic inflammatory pain displayed anxiety-like behaviors, increased the excitability of ACC PNs, and reduced inhibitory presynaptic transmission; however, the number of GAD65/67 was not altered. Interestingly, intra-ACC injection of the GABAAR agonist muscimol relieved anxiety-like behaviors but had no effect on chronic inflammatory pain. Intra-ACC injection of the GABAAR antagonist picrotoxin induced anxiety-like behaviors but had no effect on pain in normal rats. Notably, chemogenetic activation of GABAergic neurons in the ACC alleviated chronic inflammatory pain and pain-induced anxiety-like behaviors, enhanced inhibitory presynaptic transmission, and reduced the excitability of ACC PNs. Chemogenetic inhibition of GABAergic neurons in the ACC led to pain-induced anxiety-like behaviors, reduced inhibitory presynaptic transmission, and enhanced the excitability of ACC PNs but had no effect on pain in normal rats. We demonstrate that the GABAergic system mediates a reduction in inhibitory presynaptic transmission in the ACC, which leads to enhanced excitability of pyramidal neurons in the ACC and is associated with chronic inflammatory pain-related anxiety.


Anxiety/physiopathology , Chronic Pain/physiopathology , GABAergic Neurons/physiology , Gyrus Cinguli/physiopathology , Inflammation/psychology , Pyramidal Cells/physiology , Animals , Anti-Anxiety Agents/administration & dosage , Anti-Anxiety Agents/pharmacology , Anti-Anxiety Agents/therapeutic use , Anxiety/drug therapy , Anxiety/etiology , Central Nervous System Sensitization/drug effects , Chronic Pain/psychology , Clozapine/therapeutic use , Freund's Adjuvant/toxicity , GABA-A Receptor Agonists/administration & dosage , GABA-A Receptor Agonists/pharmacology , GABA-A Receptor Agonists/therapeutic use , GABA-A Receptor Antagonists/administration & dosage , GABA-A Receptor Antagonists/pharmacology , GABA-A Receptor Antagonists/toxicity , GABAergic Neurons/enzymology , Genetic Vectors/pharmacology , Inflammation/chemically induced , Inflammation/physiopathology , Injections , Interneurons/drug effects , Male , Muscimol/administration & dosage , Muscimol/pharmacology , Muscimol/therapeutic use , Open Field Test , Pain Threshold/drug effects , Patch-Clamp Techniques , Picrotoxin/toxicity , Presynaptic Terminals/drug effects , Presynaptic Terminals/physiology , Pyramidal Cells/enzymology , Rats , Rats, Sprague-Dawley
...